Catalyst Wire Dossier Catalyst Wire Dossier

Norovirus GI.1/GII.4 bivalent virus-like particle vaccine

Norovirus GI.1/GII.4 virus-like particle vaccine · Takeda
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Norovirus GI.1/GII.4 bivalent virus-like particle vaccine, covering 2016-08-01 to 2021-06-10. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-like Particle Vaccine in Adults [Phase 2]

See pricing